U 83836E

Drug Profile

U 83836E

Latest Information Update: 23 Sep 1998

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Pharmacia Corporation
  • Developer Nonindustrial source
  • Class Anti-ischaemics; Antiallergics; Antiasthmatics; Antihyperglycaemics; Bronchodilators
  • Mechanism of Action Antioxidants; Free radical scavengers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Asthma; Coronary disorders; Diabetic complications

Most Recent Events

  • 23 Sep 1998 No-Development-Reported for Coronary disorders in Italy (Unknown route)
  • 03 Aug 1998 No-Development-Reported for Diabetic complications in Italy (Unknown route)
  • 20 Jan 1997 Preclinical development for Coronary disorders (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top